BioNTech Eyes Construction Start for African Vaccine Factory in Mid-2022

Test tubes are seen in front of a displayed Biontech logo in this illustration taken, May 21, 2021. REUTERS/Dado Ruvic
Test tubes are seen in front of a displayed Biontech logo in this illustration taken, May 21, 2021. REUTERS/Dado Ruvic
TT

BioNTech Eyes Construction Start for African Vaccine Factory in Mid-2022

Test tubes are seen in front of a displayed Biontech logo in this illustration taken, May 21, 2021. REUTERS/Dado Ruvic
Test tubes are seen in front of a displayed Biontech logo in this illustration taken, May 21, 2021. REUTERS/Dado Ruvic

Germany's BioNTech, which developed a coronavirus jab with US pharmaceutical giant Pfizer, said Tuesday it aims to begin building a vaccine plant in Africa next year.

The project is expected to address the continent's shortage of COVID-19 vaccines and boost its flagging vaccination drive, with only 5.2 percent of its population fully inoculated, according to the Africa CDC.

BioNTech said it was working with authorities in both Rwanda and Senegal and plans to begin construction "in mid-2022".

The plant will initially have capacity to produce around 50 million vaccine doses per year, the German company said.

BioNTech had in August announced plans to build "sustainable vaccine production capabilities" in Rwanda and Senegal, producing not only COVID-19 vaccines but also mRNA-based malaria and tuberculosis vaccines.

“Together, we will work on developing a regional manufacturing network to support the access to vaccines manufactured in Africa, for Africa,” Chief Executive of BioNTech Ugur Sahin said.

In July, Pfizer and BioNTech announced that they were partnering with the Biovac Group to bottle their COVID-19 vaccine in Cape Town, South Africa, beginning in 2022.

However, the creation of the messenger RNA—the most delicate and crucial step—will continue to be carried out in Europe.

Currently, just one percent of vaccines used in Africa are manufactured on the continent. The African Union wants to increase this proportion to 60 percent by 2040.

US pharmaceutical giant Moderna earlier this month also announced plans to build a vaccine plant in Africa.

Africa, home to 1.2 billion people, is the least vaccinated continent in the world.

Test tubes are seen in front of a displayed Biontech logo in this illustration taken, May 21, 2021. REUTERS/Dado Ruvic



Russia: Hypersonic Missile Strike on Ukraine Was a Warning to 'Reckless' West

Russian President Vladimir Putin makes a televised address, dedicated to a military conflict in Ukraine and in particular to Russia's launch of a hypersonic intermediate-range ballistic missile attack on a military facility in response to recent Ukrainian long-range strikes with Western weapons, in Moscow, Russia November 21, 2024. Sputnik/Vyacheslav Prokofyev/Pool via REUTERS
Russian President Vladimir Putin makes a televised address, dedicated to a military conflict in Ukraine and in particular to Russia's launch of a hypersonic intermediate-range ballistic missile attack on a military facility in response to recent Ukrainian long-range strikes with Western weapons, in Moscow, Russia November 21, 2024. Sputnik/Vyacheslav Prokofyev/Pool via REUTERS
TT

Russia: Hypersonic Missile Strike on Ukraine Was a Warning to 'Reckless' West

Russian President Vladimir Putin makes a televised address, dedicated to a military conflict in Ukraine and in particular to Russia's launch of a hypersonic intermediate-range ballistic missile attack on a military facility in response to recent Ukrainian long-range strikes with Western weapons, in Moscow, Russia November 21, 2024. Sputnik/Vyacheslav Prokofyev/Pool via REUTERS
Russian President Vladimir Putin makes a televised address, dedicated to a military conflict in Ukraine and in particular to Russia's launch of a hypersonic intermediate-range ballistic missile attack on a military facility in response to recent Ukrainian long-range strikes with Western weapons, in Moscow, Russia November 21, 2024. Sputnik/Vyacheslav Prokofyev/Pool via REUTERS

The Kremlin said on Friday that a strike on Ukraine using a newly developed hypersonic ballistic missile was designed as a message to the West that Moscow will respond to their "reckless" decisions and actions in support of Ukraine.
Kremlin spokesman Dmitry Peskov was speaking a day after President Vladimir Putin said Moscow had fired the new missile - the Oreshnik or Hazel Tree - at a Ukrainian military facility.
"The main message is that the reckless decisions and actions of Western countries that produce missiles, supply them to Ukraine and subsequently participate in strikes on Russian territory cannot remain without a reaction from the Russian side," Peskov told reporters.
"The Russian side has clearly demonstrated its capabilities, and the contours of further retaliatory actions in the event that our concerns are not taken into account have been quite clearly outlined,” Reuters quoted him as saying.
Peskov said Russia had not been obliged to warn the United States about the strike, but had informed the US 30 minutes before the launch anyway.
President Vladimir Putin remained open to dialogue, Peskov said, but he said the outgoing administration of US President Joe Biden "prefers to continue down the path of escalation".
Putin said on Thursday that Russia had fired the new missile after Ukraine, with approval from the Biden administration, struck Russia with six US-made ATACMS missiles on Tuesday and with British Storm Shadow cruise missiles and US-made HIMARS on Thursday.
He said this meant that the Ukraine war had now "acquired elements of a global character".
Ukrainian President Volodymyr Zelenskiy has said Russia's use of the new missile amounted to "a clear and severe escalation" in the war and called for strong worldwide condemnation.